Relay Therapeutics (RLAY) Amortizatization of Intangibles (2019 - 2026)
Relay Therapeutics' (RLAY) quarterly Amortizatization of Intangibles came in at $782000.0 in Q1 2026, down 51.03% year-on-year from $1.6 million in Q1 2025, and down 8.75% on a QoQ basis from $857000.0 in Q4 2025.
Relay Therapeutics (RLAY) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has 8 years of Amortizatization of Intangibles data on file, last reported at $782000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 51.03% year-over-year to $782000.0 in Q1 2026; TTM through Mar 2026 was $4.1 million, a 59.66% decrease from a year earlier, with the FY2025 full-year figure at $4.9 million, down 59.81% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $782000.0, down from $857000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for RLAY reached as high as $3.7 million in Q4 2023 and fell as low as -$681000.0 in Q1 2022.
- Historically, Amortizatization of Intangibles has averaged $1.6 million across 5 years, with a median of $1.6 million in 2025.
- Across the five-year window, Amortizatization of Intangibles tumbled 345.1% in 2022 and jumped 945.88% in 2023, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $385000.0 in 2022, then soared by 852.99% to $3.7 million in 2023, then plunged by 40.56% to $2.2 million in 2024, then tumbled by 60.71% to $857000.0 in 2025, then dropped by 8.75% to $782000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $782000.0 in Q1 2026, $857000.0 in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Relay Therapeutics | 3.35 Bn | 3.35 Bn | - | 782,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 782,000.00 |
| Mar 31, 2026 | 782,000.00 |
| Dec 31, 2025 | 857,000.00 |
| Dec 31, 2025 | 857,000.00 |
| Sep 30, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | 2.18 Mn |
| Dec 31, 2024 | 2.18 Mn |
| Sep 30, 2024 | 3.18 Mn |
| Sep 30, 2024 | 3.18 Mn |
| Jun 30, 2024 | 3.29 Mn |
| Jun 30, 2024 | 3.29 Mn |
| Mar 31, 2024 | 3.67 Mn |
| Mar 31, 2024 | 3.67 Mn |
| Dec 31, 2023 | 3.67 Mn |
| Dec 31, 2023 | 3.67 Mn |